Pharmacogenomics in the newborn
Genetic variation is an important determinant affecting the individual response to drugs. Considering the high variability in each individual genotype, the development of individualized therapies, according to the intrinsic features of the single patient, represents one of the most challenging probl...
Saved in:
Main Authors: | Mirta Corsello (Author), Iliana Bersani (Author), Natalia Chukhlantseva (Author), Andrea Dotta (Author) |
---|---|
Format: | Book |
Published: |
Hygeia Press di Corridori Marinella,
2013-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel Coronavirus disease (COVID-19) in newborns and infants: what we know so far
by: Domenico Umberto De Rose, et al.
Published: (2020) -
Pharmacogenomics of hyaluronic acid
by: Elena E. Vaiman, et al.
Published: (2021) -
Editorial: NSAIDs Pharmacogenomics
by: José A. G. Agúndez, et al.
Published: (2021) -
PHARMACOGENOMICS OF PROSTAGLANDIN AND LEUKOTRIENE RECEPTORS
by: José Antonio Cornejo-García, et al.
Published: (2016) -
Medicine balls training in the sequence of complex handball training versus only handball training: effects on physical fitness in pre-adolescence female handball players
by: Natalia Chukhlantseva
Published: (2023)